TwitterLinkedinWhatsAppTelegramTelegram
0

Fatty acid profiles and iodine value correlations between 4 carcass fat depots from pigs fed varied combinations of ractopamine and energy

The iodine value of one fat depot may not be a good indication of iodine value of other fat depots.

7 February 2012
TwitterLinkedinWhatsAppTelegramTelegram
0

Diets containing ractopamine have been shown by numerous researchers to improve ADG and feed efficiency in finishing pigs. Additionally, pigs fed ractopamine diets exhibit decreased subcutaneous fat and greater lean meat yield. A total of 54 finishing barrows (initial BW = 99.8 ± 5.1 kg; PIC C22 × 337) reared in individual pens were allotted to 1 of 6 dietary treatments in a 2 × 3 factorial arrangement of treatments with 2 levels of ractopamine (0 and 7.4 mg/kg) and 3 levels of dietary energy (high: 3,537, medium: 3,369, and low: 3,317 kcal/kg of ME) to determine the effects of feeding ractopamine and various dietary energy levels on the fatty acid profile of 4 carcass fat depots (jowl, belly, subcutaneous loin, and intramuscular) and the predictive relationships of calculated iodine value (IV) between these 4 fat depots.

Feeding ractopamine diets reduced (P < 0.05) total SFA in subcutaneous fat (SCF) and intramuscular fat (IMF) and increased (P = 0.04) total MUFA in SC. Also, feeding ractopamine diets increased (P < 0.01) the IV of IMF. Total MUFA of belly fat was reduced (P < 0.05) when the low-energy diet was fed compared with the high-energy diet. Jowl fat total MUFA was reduced (P < 0.05) and total PUFA was increased (P < 0.05) when the medium-energy diet was fed compared with the high- and low-energy diets. Iodine values, independent of treatment, were 60.97, 64.51, 55.59, and 58.26 for belly, jowl, IMF, and SC fat depots, respectively. The IV correlations within fat depots were not consistent across dietary treatments because of the effect of treatments on carcass fatty acid characteristics. Feeding ractopamine diets shifted the fatty acid profile from SFA to MUFA in the SC depot. Feeding ractopamine diets did not change belly fat profiles, thus avoiding the potential negative effect of softening belly fat, which is detrimental to processing value. The IV of one fat depot may not be a good indication of IV of other fat depots because of weak correlation coefficients and the apparent influence of dietary treatment.

BR Wiegand, RB Hinson, MJ Ritter, SN Carr and GL Allee, 2011. Journal of Animal Science, 89: 3580-3586 http://dx.doi.org/10.2527/jas.2010-3302

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

Related articles

EU - EFSA evaluates safety of Ractopamine in feed

08-Apr-2009
EFSA’s FEEDAP Panel has just published an opinion on the safety of ractopamine, a growth promoter used in animal feed in some countries outside the EU. EFSA’s FEEDAP Panel found weaknesses in the data underlying the JECFA assessment which would undermine any proposal for a maximum residue level for ractopamine. The Panel found that the study on cardiovascular effects in humans cannot be taken as a basis to derive an Acceptable Daily Intake (ADI) of 0-1 micrograms per kilogramme of body weight per day as proposed by JECFA. EFSA consulted the Community Reference Laboratory responsible for beta-agonists and the European Medicines Agency (EMEA) and included the results of this process in its final opinion.